Loading...

Mary Feng, MD

TitleAssociate Professor
SchoolUCSF School of Medicine
DepartmentRadiation Oncology
AddressLocation Required
Varies CA 00000
vCardDownload vCard

    Collapse ORNG Applications 
    Collapse Clinical Trials

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Pollom EL, Lee K, Durkee BY, Grade M, Mokhtari DA, Wahl DR, Feng M, Kothary N, Koong AC, Owens DK, Goldhaber-Fiebert J, Chang DT. Cost-effectiveness of Stereotactic Body Radiation Therapy versus Radiofrequency Ablation for Hepatocellular Carcinoma: A Markov Modeling Study. Radiology. 2017 May; 283(2):460-468. PMID: 28045603.
      View in: PubMed
    2. Moran JM, Feng M, Benedetti LA, Marsh R, Griffith KA, Matuszak MM, Hess M, McMullen M, Fisher JH, Nurushev T, Grubb M, Gardner S, Nielsen D, Jagsi R, Hayman JA, Pierce LJ. Development of a model web-based system to support a statewide quality consortium in radiation oncology. Pract Radiat Oncol. 2017 May - Jun; 7(3):e205-e213. PMID: 28196607.
      View in: PubMed
    3. Wu VW, Epelman MA, Wang H, Edwin Romeijn H, Feng M, Cao Y, Ten Haken RK, Matuszak MM. Optimizing global liver function in radiation therapy treatment planning. Phys Med Biol. 2016 Sep 07; 61(17):6465-84. PMID: 27518786.
      View in: PubMed
    4. Wahl DR, Tao Y, Schipper M, Lawrence TS, Feng M. Reply to Yang et al and De Bari et al. J Clin Oncol. 2016 Aug 10; 34(23):2799. PMID: 27325853; PMCID: PMC5019762 [Available on 08/10/17].
    5. Sapir E, Tao Y, Feng F, Samuels S, El Naqa I, Murdoch-Kinch CA, Feng M, Schipper M, Eisbruch A. Predictors of Dysgeusia in Patients With Oropharyngeal Cancer Treated With Chemotherapy and Intensity Modulated Radiation Therapy. Int J Radiat Oncol Biol Phys. 2016 Oct 01; 96(2):354-361. PMID: 27473816.
      View in: PubMed
    6. Younge KC, Lee C, Moran JM, Feng M, Novelli P, Prisciandaro JI. Failure mode and effects analysis in a dual-product microsphere brachytherapy environment. Pract Radiat Oncol. 2016 Nov - Dec; 6(6):e299-e306. PMID: 27155761.
      View in: PubMed
    7. Shilkrut M, Sapir E, Hanasoge S, Schipper MJ, Normolle DP, Ben-Josef E, Ensminger W, Lawrence TS, Feng M. Phase I Trial of Dose-escalated Whole Liver Irradiation With Hepatic Arterial Fluorodeoxyuridine/Leucovorin and Streptozotocin Followed by Fluorodeoxyuridine/Leucovorin and Chemoembolization for Patients With Neuroendocrine Hepatic Metastases. Am J Clin Oncol. 2016 Feb 15. PMID: 26886946.
      View in: PubMed
    8. Matuszak MM, Hadley SW, Feng M, Hayman JA, Brock KK, Burger P, Owen D, Suresh K, Schipper M, Lawrence TS, Moran JM. Enhancing safety and quality through preplanning peer review for patients undergoing stereotactic body radiation therapy. Pract Radiat Oncol. 2016 Mar-Apr; 6(2):e39-46. PMID: 26746815.
      View in: PubMed
    9. Wahl DR, Stenmark MH, Tao Y, Pollom EL, Caoili EM, Lawrence TS, Schipper MJ, Feng M. Outcomes After Stereotactic Body Radiotherapy or Radiofrequency Ablation for Hepatocellular Carcinoma. J Clin Oncol. 2016 Feb 10; 34(5):452-9. PMID: 26628466; PMCID: PMC4872011 [Available on 10/10/16].
    10. Wang H, Feng M, Jackson A, Ten Haken RK, Lawrence TS, Cao Y. Local and Global Function Model of the Liver. Int J Radiat Oncol Biol Phys. 2016 Jan 01; 94(1):181-8. PMID: 26700712; PMCID: PMC4692182 [Available on 01/01/17].
    11. Jagsi R, Griffith KA, Boike TP, Walker E, Nurushev T, Grills IS, Moran JM, Feng M, Hayman J, Pierce LJ. Differences in the Acute Toxic Effects of Breast Radiotherapy by Fractionation Schedule: Comparative Analysis of Physician-Assessed and Patient-Reported Outcomes in a Large Multicenter Cohort. JAMA Oncol. 2015 Oct; 1(7):918-30. PMID: 26247417.
      View in: PubMed
    12. Paradis E, Cao Y, Lawrence TS, Tsien C, Feng M, Vineberg K, Balter JM. Assessing the Dosimetric Accuracy of Magnetic Resonance-Generated Synthetic CT Images for Focal Brain VMAT Radiation Therapy. Int J Radiat Oncol Biol Phys. 2015 Dec 01; 93(5):1154-61. PMID: 26581151; PMCID: PMC4654706 [Available on 12/01/16].
    13. Feng M, Brunner TB, Ben-Josef E. Stereotactic Body Radiation Therapy for Liver Cancer: Effective Therapy With Minimal Impact on Quality of Life. Int J Radiat Oncol Biol Phys. 2015 Sep 01; 93(1):26-8. PMID: 26279021.
      View in: PubMed
    14. Zhou J, Fang CX, Shen J, Schipper MJ, Zalupski MM, Minter RM, Simeone DM, Hart D, Eagle T, Kimmel GW, Vainshtein J, Lawrence TS, Feng M. Definitive Chemoradiation With Full-dose Gemcitabine for Unresectable Pancreatic Cancer: Efficacy of Involved-Field Radiotherapy. Am J Clin Oncol. 2015 Jul 09. PMID: 26165418.
      View in: PubMed
    15. Davis EJ, Chugh R, Zhao L, Lucas DR, Biermann JS, Zalupski MM, Feng M, Wong SL, Jacobson J, Zyczynski L, Reinke D, Metko G, Baker LH, Schuetze SM. A randomised, open-label, phase II study of neo/adjuvant doxorubicin and ifosfamide versus gemcitabine and docetaxel in patients with localised, high-risk, soft tissue sarcoma. Eur J Cancer. 2015 Sep; 51(13):1794-802. PMID: 26066736.
      View in: PubMed
    16. Hsu SH, Cao Y, Lawrence TS, Tsien C, Feng M, Grodzki DM, Balter JM. Quantitative characterizations of ultrashort echo (UTE) images for supporting air-bone separation in the head. Phys Med Biol. 2015 Apr 07; 60(7):2869-80. PMID: 25776205; PMCID: PMC4405190.
    17. Shumway DA, Griffith KA, Pierce LJ, Feng M, Moran JM, Stenmark MH, Jagsi R, Hayman JA. Wide Variation in the Diffusion of a New Technology: Practice-Based Trends in Intensity-Modulated Radiation Therapy (IMRT) Use in the State of Michigan, With Implications for IMRT Use Nationally. J Oncol Pract. 2015 May; 11(3):e373-9. PMID: 25736383.
      View in: PubMed
    18. Siegel GW, Biermann JS, Chugh R, Jacobson JA, Lucas D, Feng M, Chang AC, Smith SR, Wong SL, Hasen J. The multidisciplinary management of bone and soft tissue sarcoma: an essential organizational framework. J Multidiscip Healthc. 2015; 8:109-15. PMID: 25733913; PMCID: PMC4340372.
    19. Jagsi R, Griffith KA, Heimburger D, Walker EM, Grills IS, Boike T, Feng M, Moran JM, Hayman J, Pierce LJ. Choosing wisely? Patterns and correlates of the use of hypofractionated whole-breast radiation therapy in the state of Michigan. Int J Radiat Oncol Biol Phys. 2014 Dec 01; 90(5):1010-6. PMID: 25539366.
      View in: PubMed
    20. Cuneo KC, Chenevert TL, Ben-Josef E, Feng MU, Greenson JK, Hussain HK, Simeone DM, Schipper MJ, Anderson MA, Zalupski MM, Al-Hawary M, Galban CJ, Rehemtulla A, Feng M, Lawrence TS, Ross BD. A pilot study of diffusion-weighted MRI in patients undergoing neoadjuvant chemoradiation for pancreatic cancer. Transl Oncol. 2014 Oct; 7(5):644-9. PMID: 25389460; PMCID: PMC4225651.
    21. Feng M, Pierce LJ. Getting to the heart of the matter. J Natl Cancer Inst. 2014 Aug; 106(8). PMID: 25128696.
      View in: PubMed
    22. Tran LK, Maturen KE, Feng M, Wizauer EJ, Watcharotone K, Parker RA, Ellis JH. Renal remodeling after abdominal radiation therapy: parenchymal and functional changes. AJR Am J Roentgenol. 2014 Aug; 203(2):W192-8. PMID: 25055293.
      View in: PubMed
    23. Tempero MA, Malafa MP, Behrman SW, Benson AB, Casper ES, Chiorean EG, Chung V, Cohen SJ, Czito B, Engebretson A, Feng M, Hawkins WG, Herman J, Hoffman JP, Ko A, Komanduri S, Koong A, Lowy AM, Ma WW, Merchant NB, Mulvihill SJ, Muscarella P, Nakakura EK, Obando J, Pitman MB, Reddy S, Sasson AR, Thayer SP, Weekes CD, Wolff RA, Wolpin BM, Burns JL, Freedman-Cass DA. Pancreatic adenocarcinoma, version 2.2014: featured updates to the NCCN guidelines. J Natl Compr Canc Netw. 2014 Aug; 12(8):1083-93. PMID: 25099441.
      View in: PubMed
    24. Hong TS, Bosch WR, Krishnan S, Kim TK, Mamon HJ, Shyn P, Ben-Josef E, Seong J, Haddock MG, Cheng JC, Feng M, Stephans KL, Roberge D, Crane C, Dawson LA. Interobserver variability in target definition for hepatocellular carcinoma with and without portal vein thrombus: radiation therapy oncology group consensus guidelines. Int J Radiat Oncol Biol Phys. 2014 Jul 15; 89(4):804-13. PMID: 24969794; PMCID: PMC4285340.
    25. Cuneo KC, Davis MA, Feng M, Novelli PM, Ensminger WD, Lawrence TS. Low dose rate radiosensitization of hepatocellular carcinoma in vitro and in patients. Transl Oncol. 2014 Aug; 7(4):472-8. PMID: 24956939; PMCID: PMC4202782.
    26. Stenmark MH, Cao Y, Wang H, Jackson A, Ben-Josef E, Ten Haken RK, Lawrence TS, Feng M. Estimating functional liver reserve following hepatic irradiation: adaptive normal tissue response models. Radiother Oncol. 2014 Jun; 111(3):418-23. PMID: 24813090; PMCID: PMC4119482.
    27. Wang H, Farjam R, Feng M, Hussain H, Ten Haken RK, Lawrence TS, Cao Y. Arterial perfusion imaging-defined subvolume of intrahepatic cancer. Int J Radiat Oncol Biol Phys. 2014 May 01; 89(1):167-74. PMID: 24613814; PMCID: PMC3988211.
    28. Welling TH, Feng M, Wan S, Hwang SY, Volk ML, Lawrence TS, Zalupski MM, Sonnenday CJ. Neoadjuvant stereotactic body radiation therapy, capecitabine, and liver transplantation for unresectable hilar cholangiocarcinoma. Liver Transpl. 2014 Jan; 20(1):81-8. PMID: 24115315; PMCID: PMC4185427.
    29. Hsu SH, Cao Y, Huang K, Feng M, Balter JM. Investigation of a method for generating synthetic CT models from MRI scans of the head and neck for radiation therapy. Phys Med Biol. 2013 Dec 07; 58(23):8419-35. PMID: 24217183; PMCID: PMC3886820.
    30. Hunter KU, Fernandes LL, Vineberg KA, McShan D, Antonuk AE, Cornwall C, Feng M, Schipper MJ, Balter JM, Eisbruch A. Parotid glands dose-effect relationships based on their actually delivered doses: implications for adaptive replanning in radiation therapy of head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2013 Nov 15; 87(4):676-82. PMID: 24035328; PMCID: PMC3805710.
    31. Liu E, Stenmark MH, Schipper MJ, Balter JM, Kessler ML, Caoili EM, Lee OE, Ben-Josef E, Lawrence TS, Feng M. Stereotactic body radiation therapy for primary and metastatic liver tumors. Transl Oncol. 2013 Aug; 6(4):442-6. PMID: 23908687; PMCID: PMC3730019.
    32. Wilkie JR, Matuszak MM, Feng M, Moran JM, Fraass BA. Use of plan quality degradation to evaluate tradeoffs in delivery efficiency and clinical plan metrics arising from IMRT optimizer and sequencer compromises. Med Phys. 2013 Jul; 40(7):071708. PMID: 23822412; PMCID: PMC3695972.
    33. Wang H, Feng M, Frey KA, Ten Haken RK, Lawrence TS, Cao Y. Predictive models for regional hepatic function based on 99mTc-IDA SPECT and local radiation dose for physiologic adaptive radiation therapy. Int J Radiat Oncol Biol Phys. 2013 Aug 01; 86(5):1000-6. PMID: 23688813; PMCID: PMC3710542.
    34. Tran LK, Maturen KE, Feng M, Wizauer E, Watcharotone K, Ellis JH. Renal remodeling in the first 24 months after abdominal radiotherapy. Pract Radiat Oncol. 2013 Apr-Jun; 3(2 Suppl 1):S6. PMID: 24674564.
      View in: PubMed
    35. Wang H, Feng M, Frey K, Balter J, Haken RT, Lawrence T, Cao Y. Hepatic Function Model Based Upon HIDA SPECT and Dose for Physiological Adaptive RT. Pract Radiat Oncol. 2013 Apr-Jun; 3(2 Suppl 1):S2. PMID: 24674506.
      View in: PubMed
    36. Maturen KE, Feng M, Wasnik AP, Azar SF, Appelman HD, Francis IR, Platt JF. Imaging effects of radiation therapy in the abdomen and pelvis: evaluating "innocent bystander" tissues. Radiographics. 2013 Mar-Apr; 33(2):599-619. PMID: 23479716.
      View in: PubMed
    37. Chung E, Corbett JR, Moran JM, Griffith KA, Marsh RB, Feng M, Jagsi R, Kessler ML, Ficaro EC, Pierce LJ. Is there a dose-response relationship for heart disease with low-dose radiation therapy? Int J Radiat Oncol Biol Phys. 2013 Mar 15; 85(4):959-64. PMID: 23021709.
      View in: PubMed
    38. Long T, Matuszak M, Feng M, Fraass BA, Ten Haken RK, Romeijn HE. Sensitivity analysis for lexicographic ordering in radiation therapy treatment planning. Med Phys. 2012 Jun; 39(6):3445-55. PMID: 22755724; PMCID: PMC3371080.
    39. Feng M, Demiroz C, Vineberg KA, Eisbruch A, Balter JM. Normal tissue anatomy for oropharyngeal cancer: contouring variability and its impact on optimization. Int J Radiat Oncol Biol Phys. 2012 Oct 01; 84(2):e245-9. PMID: 22583602; PMCID: PMC3432166.
    40. Feng M, Normolle D, Pan CC, Dawson LA, Amarnath S, Ensminger WD, Lawrence TS, Ten Haken RK. Dosimetric analysis of radiation-induced gastric bleeding. Int J Radiat Oncol Biol Phys. 2012 Sep 01; 84(1):e1-6. PMID: 22541965; PMCID: PMC3423508.
    41. Cao Y, Wang H, Johnson TD, Pan C, Hussain H, Balter JM, Normolle D, Ben-Josef E, Ten Haken RK, Lawrence TS, Feng M. Prediction of liver function by using magnetic resonance-based portal venous perfusion imaging. Int J Radiat Oncol Biol Phys. 2013 Jan 01; 85(1):258-63. PMID: 22520476; PMCID: PMC3629546.
    42. Sabolch A, Feng M, Griffith K, Rzasa C, Gadzala L, Feng F, Biermann JS, Chugh R, Ray M, Ben-Josef E. Risk factors for local recurrence and metastasis in soft tissue sarcomas of the extremity. Am J Clin Oncol. 2012 Apr; 35(2):151-7. PMID: 21336091.
      View in: PubMed
    43. Feng M, Smith DE, Normolle DP, Knol JA, Pan CC, Ben-Josef E, Lu Z, Feng M, Chen J, Ensminger W, Lawrence TS. A phase I clinical and pharmacology study using amifostine as a radioprotector in dose-escalated whole liver radiation therapy. Int J Radiat Oncol Biol Phys. 2012 Aug 01; 83(5):1441-7. PMID: 22440042; PMCID: PMC3383372.
    44. Rubin JM, Feng M, Hadley SW, Fowlkes JB, Hamilton JD. Potential use of ultrasound speckle tracking for motion management during radiotherapy: preliminary report. J Ultrasound Med. 2012 Mar; 31(3):469-81. PMID: 22368138.
      View in: PubMed
    45. Stenmark MH, Vineberg K, Ten Haken RK, Hamstra DA, Feng M. Dosimetric implications of residual seminal vesicle motion in fiducial-guided intensity-modulated radiotherapy for prostate cancer. Med Dosim. 2012; 37(3):240-4. PMID: 22189029.
      View in: PubMed
    46. Pak D, Vineberg KA, Griffith KA, Sabolch A, Chugh R, Ben-Josef E, Biermann JS, Feng M. Dose--effect relationships for femoral fractures after multimodality limb-sparing therapy of soft-tissue sarcomas of the proximal lower extremity. Int J Radiat Oncol Biol Phys. 2012 Jul 15; 83(4):1257-63. PMID: 22099042.
      View in: PubMed
    47. Feng M, Ben-Josef E. Radiation therapy for hepatocellular carcinoma. Semin Radiat Oncol. 2011 Oct; 21(4):271-7. PMID: 21939856.
      View in: PubMed
    48. Sabolch A, Feng M, Griffith K, Hammer G, Doherty G, Ben-Josef E. Adjuvant and definitive radiotherapy for adrenocortical carcinoma. Int J Radiat Oncol Biol Phys. 2011 Aug 01; 80(5):1477-84. PMID: 20675074.
      View in: PubMed
    49. Feng FY, Kim HM, Lyden TH, Haxer MJ, Worden FP, Feng M, Moyer JS, Prince ME, Carey TE, Wolf GT, Bradford CR, Chepeha DB, Eisbruch A. Intensity-modulated chemoradiotherapy aiming to reduce dysphagia in patients with oropharyngeal cancer: clinical and functional results. J Clin Oncol. 2010 Jun 01; 28(16):2732-8. PMID: 20421546; PMCID: PMC2881852.
    50. Feng M, Moran JM, Koelling T, Chughtai A, Chan JL, Freedman L, Hayman JA, Jagsi R, Jolly S, Larouere J, Soriano J, Marsh R, Pierce LJ. Development and validation of a heart atlas to study cardiac exposure to radiation following treatment for breast cancer. Int J Radiat Oncol Biol Phys. 2011 Jan 01; 79(1):10-8. PMID: 20421148; PMCID: PMC2937165.
    51. McLaughlin PW, Evans C, Feng M, Narayana V. Radiographic and anatomic basis for prostate contouring errors and methods to improve prostate contouring accuracy. Int J Radiat Oncol Biol Phys. 2010 Feb 01; 76(2):369-78. PMID: 19515511.
      View in: PubMed
    52. Feng M, Balter JM, Normolle D, Adusumilli S, Cao Y, Chenevert TL, Ben-Josef E. Characterization of pancreatic tumor motion using cine MRI: surrogates for tumor position should be used with caution. Int J Radiat Oncol Biol Phys. 2009 Jul 01; 74(3):884-91. PMID: 19395190; PMCID: PMC2691867.
    53. Feng M, Kong FM, Gross M, Fernando S, Hayman JA, Ten Haken RK. Using fluorodeoxyglucose positron emission tomography to assess tumor volume during radiotherapy for non-small-cell lung cancer and its potential impact on adaptive dose escalation and normal tissue sparing. Int J Radiat Oncol Biol Phys. 2009 Mar 15; 73(4):1228-34. PMID: 19251094; PMCID: PMC3381895.
    54. Feng M, Murphy J, Griffith KA, Baker LH, Sondak VK, Lucas DR, McGinn CJ, Ray ME. Long-term outcomes after radiotherapy for retroperitoneal and deep truncal sarcoma. Int J Radiat Oncol Biol Phys. 2007 Sep 01; 69(1):103-10. PMID: 17560050.
      View in: PubMed
    55. Feng FY, Kim HM, Lyden TH, Haxer MJ, Feng M, Worden FP, Chepeha DB, Eisbruch A. Intensity-modulated radiotherapy of head and neck cancer aiming to reduce dysphagia: early dose-effect relationships for the swallowing structures. Int J Radiat Oncol Biol Phys. 2007 Aug 01; 68(5):1289-98. PMID: 17560051.
      View in: PubMed
    56. Feng M, Hanlon AL, Pisansky TM, Kuban D, Catton CN, Michalski JM, Zelefsky MJ, Kupelian PA, Pollack A, Kestin LL, Valicenti RK, DeWeese TL, Sandler HM. Predictive factors for late genitourinary and gastrointestinal toxicity in patients with prostate cancer treated with adjuvant or salvage radiotherapy. Int J Radiat Oncol Biol Phys. 2007 Aug 01; 68(5):1417-23. PMID: 17418972.
      View in: PubMed
    57. Feng M, Eisbruch A. Future issues in highly conformal radiotherapy for head and neck cancer. J Clin Oncol. 2007 Mar 10; 25(8):1009-13. PMID: 17350951.
      View in: PubMed
    58. Feng M, Ben-Josef E. Adjuvant therapy for pancreatic cancer: the glass is half empty. Nat Clin Pract Oncol. 2007 Mar; 4(3):148-9. PMID: 17245345.
      View in: PubMed
    59. Jabbari S, Kim HM, Feng M, Lin A, Tsien C, Elshaikh M, Terrel JE, Murdoch-Kinch C, Eisbruch A. Matched case-control study of quality of life and xerostomia after intensity-modulated radiotherapy or standard radiotherapy for head-and-neck cancer: initial report. Int J Radiat Oncol Biol Phys. 2005 Nov 01; 63(3):725-31. PMID: 16199308.
      View in: PubMed
    60. Feng M, Jabbari S, Lin A, Bradford CR, Chepeha DB, Teknos TN, Worden FP, Tsien C, Schipper MJ, Wolf GT, Dawson LA, Eisbruch A. Predictive factors of local-regional recurrences following parotid sparing intensity modulated or 3D conformal radiotherapy for head and neck cancer. Radiother Oncol. 2005 Oct; 77(1):32-8. PMID: 16154219.
      View in: PubMed
    Mary's Networks
    Concepts
    Derived automatically from this person's publications.
    _
    Co-Authors
    People in Profiles who have published with this person.
    _
    Related Authors
    People who share related concepts with this person.
    _
    Back to TOP